|
US4650764A
(en)
|
1983-04-12 |
1987-03-17 |
Wisconsin Alumni Research Foundation |
Helper cell
|
|
US5059421A
(en)
|
1985-07-26 |
1991-10-22 |
The Liposome Company, Inc. |
Preparation of targeted liposome systems of a defined size distribution
|
|
US4980289A
(en)
|
1987-04-27 |
1990-12-25 |
Wisconsin Alumni Research Foundation |
Promoter deficient retroviral vector
|
|
US5082670A
(en)
|
1988-12-15 |
1992-01-21 |
The Regents Of The University Of California |
Method of grafting genetically modified cells to treat defects, disease or damage or the central nervous system
|
|
US5124263A
(en)
|
1989-01-12 |
1992-06-23 |
Wisconsin Alumni Research Foundation |
Recombination resistant retroviral helper cell and products produced thereby
|
|
US5328470A
(en)
|
1989-03-31 |
1994-07-12 |
The Regents Of The University Of Michigan |
Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor
|
|
US5399346A
(en)
|
1989-06-14 |
1995-03-21 |
The United States Of America As Represented By The Department Of Health And Human Services |
Gene therapy
|
|
US5585362A
(en)
|
1989-08-22 |
1996-12-17 |
The Regents Of The University Of Michigan |
Adenovirus vectors for gene therapy
|
|
US6497872B1
(en)
|
1991-07-08 |
2002-12-24 |
Neurospheres Holdings Ltd. |
Neural transplantation using proliferated multipotent neural stem cells and their progeny
|
|
US5350674A
(en)
|
1992-09-04 |
1994-09-27 |
Becton, Dickinson And Company |
Intrinsic factor - horse peroxidase conjugates and a method for increasing the stability thereof
|
|
EP0673431A1
(en)
|
1992-12-03 |
1995-09-27 |
Genzyme Corporation |
Gene therapy for cystic fibrosis
|
|
US5631237A
(en)
|
1992-12-22 |
1997-05-20 |
Dzau; Victor J. |
Method for producing in vivo delivery of therapeutic agents via liposomes
|
|
FR2705361B1
(fr)
|
1993-05-18 |
1995-08-04 |
Centre Nat Rech Scient |
Vecteurs viraux et utilisation en thérapie génique.
|
|
FR2705686B1
(fr)
|
1993-05-28 |
1995-08-18 |
Transgene Sa |
Nouveaux adénovirus défectifs et lignées de complémentation correspondantes.
|
|
CA2163860A1
(en)
|
1993-06-30 |
1995-01-12 |
Chung C. Hsu |
Method for preparing liposomes
|
|
CA2144040A1
(fr)
|
1993-07-13 |
1995-01-26 |
Michel Perricaudet |
Vecteurs adenoviraux defectifs et utilisation en therapie genique
|
|
US5885613A
(en)
|
1994-09-30 |
1999-03-23 |
The University Of British Columbia |
Bilayer stabilizing components and their use in forming programmable fusogenic liposomes
|
|
IL116816A
(en)
|
1995-01-20 |
2003-05-29 |
Rhone Poulenc Rorer Sa |
Cell for the production of a defective recombinant adenovirus or an adeno-associated virus and the various uses thereof
|
|
US5643599A
(en)
|
1995-06-07 |
1997-07-01 |
President And Fellows Of Harvard College |
Intracellular delivery of macromolecules
|
|
AU4645697A
(en)
|
1996-09-11 |
1998-04-02 |
Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The |
Aav4 vector and uses thereof
|
|
US6245564B1
(en)
|
1997-01-23 |
2001-06-12 |
Cornell Research Foundation, Inc. |
Method for separating cells
|
|
US6156303A
(en)
|
1997-06-11 |
2000-12-05 |
University Of Washington |
Adeno-associated virus (AAV) isolates and AAV vectors derived therefrom
|
|
DE69939169D1
(de)
|
1998-05-28 |
2008-09-04 |
Us Gov Health & Human Serv |
Aav5 vektoren und deren verwendung
|
|
DE69936104T2
(de)
|
1998-11-05 |
2008-01-17 |
The Trustees Of The University Of Pennsylvania |
Nukleinsäuresequenzen des adeno-assoziierten virus des serotyps i, und vektoren und wirtszellen, die diese enthalten
|
|
EP1135468B1
(en)
|
1998-11-10 |
2010-01-06 |
University Of North Carolina At Chapel Hill |
Virus vectors and methods of making and administering the same
|
|
EP1235842A4
(en)
|
1999-10-15 |
2003-04-23 |
Univ Massachusetts |
Rna interference pathway genes as tools for targeted genetic interference
|
|
US6326193B1
(en)
|
1999-11-05 |
2001-12-04 |
Cambria Biosciences, Llc |
Insect control agent
|
|
US7465583B2
(en)
|
2000-06-01 |
2008-12-16 |
The University Of North Carolina At Chapel Hill |
Duplexed parvovirus vectors
|
|
WO2001096584A2
(en)
|
2000-06-12 |
2001-12-20 |
Akkadix Corporation |
Materials and methods for the control of nematodes
|
|
US20030223972A1
(en)
|
2002-02-15 |
2003-12-04 |
Goldman Steven A. |
Myelination of congenitally dysmyelinated forebrains using oligodendrocyte progenitor cells
|
|
US20040029269A1
(en)
|
2002-05-07 |
2004-02-12 |
Goldman Steven A |
Promoter-based isolation, purification, expansion, and transplantation of neuronal progenitor cells, oligodendrocyte progenitor cells, or neural stem cells from a population of embryonic stem cells
|
|
EP1668143B1
(en)
|
2003-09-30 |
2013-03-20 |
The Trustees of The University of Pennsylvania |
Adeno-associated virus (aav) clades, sequences, vectors containing same, and uses therefor
|
|
JP4428296B2
(ja)
|
2005-06-10 |
2010-03-10 |
セイコーエプソン株式会社 |
表示パネルモジュールおよび表示装置
|
|
US20100215724A1
(en)
|
2005-11-22 |
2010-08-26 |
Mcgill University |
Microcapsule Nanotube Devices for Targeted Delivery of Therapeutic Molecules
|
|
EP2206724A1
(en)
|
2005-12-13 |
2010-07-14 |
Kyoto University |
Nuclear reprogramming factor
|
|
DK2114167T3
(en)
|
2007-01-16 |
2018-09-17 |
Univ Rochester |
NON-HUMAN ANIMALS WITH HUMAN GLIAKIMARY BRAIN
|
|
DK3399025T3
(da)
|
2007-03-23 |
2025-06-16 |
Wisconsin Alumni Res Found |
Omprogrammering af somatiske celler
|
|
JP2008307007A
(ja)
|
2007-06-15 |
2008-12-25 |
Bayer Schering Pharma Ag |
出生後のヒト組織由来未分化幹細胞から誘導したヒト多能性幹細胞
|
|
EP2315829B1
(en)
|
2008-08-08 |
2015-02-11 |
Mayo Foundation For Medical Education And Research |
Induced pluripotent stem cells
|
|
WO2010045659A1
(en)
|
2008-10-17 |
2010-04-22 |
American Gene Technologies International Inc. |
Safe lentiviral vectors for targeted delivery of multiple therapeutic molecules
|
|
WO2011062963A2
(en)
|
2009-11-17 |
2011-05-26 |
Vitro Diagnositics, Inc. |
Induced puripotent stem cells and related methods
|
|
US9005967B2
(en)
|
2010-01-22 |
2015-04-14 |
Kyoto University |
Myc variants improve induced pluripotent stem cell generation efficiency
|
|
EP2771455B1
(en)
|
2011-10-28 |
2016-10-05 |
The University of North Carolina At Chapel Hill |
Cell line for production of adeno-associated virus
|
|
PL2900686T3
(pl)
|
2012-09-28 |
2021-01-25 |
The University Of North Carolina At Chapel Hill |
Wektory aav ukierunkowane na oligodendrocyty
|
|
EP3766962B1
(en)
|
2013-02-06 |
2025-10-22 |
University of Rochester |
Induced pluripotent cell-derived oligodendrocyte progenitor cells for the treatment of myelin disorders
|
|
US11136557B2
(en)
|
2013-05-31 |
2021-10-05 |
The Regents Of The University Of California |
Adeno-associated virus variants and methods of use thereof
|
|
NZ716102A
(en)
|
2013-07-22 |
2021-12-24 |
The Children’S Hospital Of Philadelphia |
Variant aav and compositions, methods and uses for gene transfer to cells, organs and tissues
|
|
GB201403684D0
(en)
|
2014-03-03 |
2014-04-16 |
King S College London |
Vector
|
|
EP4378487A3
(en)
|
2015-06-23 |
2024-09-04 |
The Children's Hospital of Philadelphia |
Modified factor ix, and compositions, methods and uses for gene transfer to cells, organs and tissues
|
|
SI3710067T1
(sl)
|
2017-11-14 |
2026-01-30 |
Arcellx, Inc. |
Polipeptidi, ki vsebujejo D-domeno, in njihova uporaba
|
|
BR112020016570A2
(pt)
|
2018-02-17 |
2020-12-15 |
Flagship Pioneering Innovations V, Inc. |
Composições e métodos para liberação de proteína de membrana
|
|
US12303549B2
(en)
*
|
2018-06-21 |
2025-05-20 |
University Of Rochester |
Methods of treating or inhibiting onset of Huntington's disease
|
|
CA3105953A1
(en)
|
2018-07-09 |
2020-01-16 |
Flagship Pioneering Innovations V, Inc. |
Fusosome compositions and uses thereof
|
|
EP3923962A2
(en)
*
|
2019-02-13 |
2021-12-22 |
University of Rochester |
Gene networks that mediate remyelination of the human brain
|
|
CN115461066B
(zh)
|
2020-04-28 |
2026-01-06 |
美国辉瑞有限公司 |
用于基因疗法的编码天冬氨酸酰化酶(aspa)的经修饰的核酸和载体
|